Cryptosporidiosis commonly causes severe diarrhea in immunosuppressed patients. There currently are no antiparasitic drugs consistently effective for this infection. This case describes a 26-year-old hemophiliac patient with acquired immunodeficiency syndrome and cryptosporidiosis whose diarrhea improved with continuous intravenous administration of a long-acting somatostatin analog, octreotide. Somatostatin has a variety of inhibitory effects on gastrointestinal hormones as well as a possible nonspecific effect on gastrointestinal mucosal fluid and electrolyte secretion. The somatostatin analog should be considered for patients with secretory diarrhea refractory to other forms of therapy.
Get full access to this article
View all access options for this article.
References
1.
SoaveR, ArmstrongD. Cryptosporidium and cryptosporidiosis.Rev Infect Dis1986; 8: 101223.
McintoshCS. Gastrointestinal somatostatin: distribution, secretion and physiologic significance, life Sci1985; 37: 204358.
4.
ChewCS. Inhibitory action of somatostatin on isolated gastric glands and parietal cells.Am J Physiol1983; 245: G221-9.
5.
VatnMH, SchrumpfE, HanssenKF, MyrenJ. The effect of somatostatin on pentagastrin-stimulated gastric secretion and on plasma gastrin in man.Scand J Gastroenterol1977; 12: 8339.
6.
GuilleminR. Somatostatin inhibits the release of acetylcholine induced electrically in the mesenteric plexus.Endocrinology1976; 99: 16534.
7.
PriceBA, JaffeBM, ZinnerMJ. Effect of exogenous somatostatin infusion on gastrointestinal blood flow and hormones in the conscious dog.Gastroenterology1985; 88: 805.
8.
BassoN, BagaraniM, BracciFRanitidine and somatostatin: their effects on bleeding from the upper gastrointestinal tract.Arch Surg1986; 121: 8335.
9.
JohanssonC, EfendicS, WisenOEffects of short-term somatostatin infusion on the gastric and intestinal propulsions in humans.Scand J Gastroenterol1978; 13: 4813.
10.
KayasschL, GyrK, StalderGAEffect of somatostatin on exocrine pancreatic secretion stimulated by pancreozymin, secretin or by a test meal in the dog.Horm Res1978; 9: 17684.
11.
CorterRF, BitarKN, ZfassAM, MackhlourGM. Inhibition of VIP-stimulated intestinal secretion and cyclic AMP production by somatostatin in the rat.Gastroenterology1978; 78: 72630.
12.
DharmsathaphornK, GorelickFS, SherwinRS. Somatostatin decreases diarrhea in patients with short-bowel syndrome.J Clin Gastroenterol1982; 4: 5214.
13.
SheppardM, ShapiroB, PimstoneBMetabolic clearance and plasma half-disappearance time of exogenous somatostatin in man.J Clin Endocrinol Metab1979; 48: 503.
14.
MulvihillS, PassaroE, DebasH, YamadaT. Severe diarrhea after colonic pseudo-obstruction: treatment with somatostatin (letter).N Engl J Med1984; 310: 4678.
15.
DavisGR, CampRG, RaskinP, KrejS. Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome.Gastroenterology1980; 78: 3469.
16.
RobertsJL, HubbardWC, BloomgardenZTProstaglandins: role in the hormonal manifestations of medullary carcinoma of the thyroid and inhibition by somatostatin.Trans Assoc Am Physicians1979; 92: 28691.
17.
MollaAM, GyrK, BardhamPK, MollaA. Effect of intravenous somatostatin on stool output in diarrhea due to Vibrio cholerae.Gastroenterology1984; 87: 8457.
18.
RobertsWG, FedorakRN, ChangEB. In vitro effects of 201-995 on intestinal ion transport: comparison of antisecretory effects with SRIF-14 and alpha-2-agonists (abstract).Gastroenterology1986; 90: 1606.
19.
FedorakRN, FieldM. Antidiarrheal therapy: prospects for new agents.Dig Dis Sci1987; 32: 195205.
20.
MatonPN, O'DORISIOTM, HoweBAEffect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.N Engl J Med1985; 312: 1721.
21.
KvolsLK, MoertelCG, O'CONNELLMJTreatment of the malignant carcinoid syndrome: evaluation of a long-acting somatostatin analogue.N Engl J Med1986; 315: 6636.
22.
WilliamsNS, CooperJC, AxonATUse of a long-acting somatostatin analogue in controlling life-threatening ileostomy diarrhea.Br Med J1984; 289: 19278.
23.
CooperJC, WilliamsNS, KingRF, BarkerMC. Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhea.Br J Surg1986; 73: 12831.
24.
BodenG, RyanIG, EisenschmidBSTreatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.N Engl J Med1986; 26: 16869.
25.
BarnardLB, GranthamWG, LambertonPTreatment of resistant acromegaly with a long-acting somatostatin analogue (SMS 201-995).Ann Intern Med1986; 105: 85661.
26.
GerichJ, LorenziM, KaramJAbnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus.JAMA1975; 234: 15965.
27.
ChristensenS, HansenA, WeeksJ24-hour studies of the effects of somatostatin on the levels of plasma growth hormone, glucagon, and glucose in normal subjects and juvenile diabetics.Diabetes1978; 27: 3006.
28.
GerichJE. Somatostatin and diabetes.Am J Med1981; 70: 61926.
29.
VoraJP, OwensDR, RyderREffect of somatostatin on renal function.Br Med J1986; 292: 17012.
